R Lambertz1, A H Hölscher1, M Bludau1, J M Leers1, C Gutschow1, W Schröder2. 1. Department of General, Visceral and Cancer Surgery, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany. 2. Department of General, Visceral and Cancer Surgery, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany. wolfgang.schroeder@uni-koeln.de.
Abstract
BACKGROUND: The development of tracheo- or bronchoesophageal fistula (TBF) after Ivor-Lewis esophagectomy remains to be a rare complication associated with a high mortality rate. METHODS: In this retrospective study, the charts of patients with TBF after esophagectomy were analyzed in terms of individual patient characteristics, esophagotracheal complications, respiratory function, management, and outcome. RESULTS: Between January 2000 and December 2014, 1204 patients underwent Ivor-Lewis esophagectomy for esophageal cancer; 13 patients (1.1 %) developed a TBF. In all 13 patients, a concomitant leakage of the intrathoracic esophagogastrostomy was evident, either prior to diagnosis of TBF (metachronous TBF) or simultaneously (synchronous TBF). TBF was predominantly located in the left main bronchus (n = 6, 46.1 %) or trachea (n = 5, 38.5 %). Management of TBF included re-thoracotomy (n = 7), interventional endoscopic (n = 10) or bronchoscopic therapy (n = 4). In the majority of patients (n = 8), management consisted of two subsequent treatment modalities. In 3 out of four patients, TBF was successfully treated by endoscopic stenting only. Five patients (38.5 %) died following a septic course with multiple organ failure. CONCLUSIONS: The development of TBF after Ivor-Lewis esophagectomy is always combined with anastomotic leakage of the esophagogastrostomy. Treatment options primarily depend on the vascularization of the gastric conduit, the severity of the concomitant aspiration pneumonia, and the volume of the air leakage.
BACKGROUND: The development of tracheo- or bronchoesophageal fistula (TBF) after Ivor-Lewis esophagectomy remains to be a rare complication associated with a high mortality rate. METHODS: In this retrospective study, the charts of patients with TBF after esophagectomy were analyzed in terms of individual patient characteristics, esophagotracheal complications, respiratory function, management, and outcome. RESULTS: Between January 2000 and December 2014, 1204 patients underwent Ivor-Lewis esophagectomy for esophageal cancer; 13 patients (1.1 %) developed a TBF. In all 13 patients, a concomitant leakage of the intrathoracic esophagogastrostomy was evident, either prior to diagnosis of TBF (metachronous TBF) or simultaneously (synchronous TBF). TBF was predominantly located in the left main bronchus (n = 6, 46.1 %) or trachea (n = 5, 38.5 %). Management of TBF included re-thoracotomy (n = 7), interventional endoscopic (n = 10) or bronchoscopic therapy (n = 4). In the majority of patients (n = 8), management consisted of two subsequent treatment modalities. In 3 out of four patients, TBF was successfully treated by endoscopic stenting only. Five patients (38.5 %) died following a septic course with multiple organ failure. CONCLUSIONS: The development of TBF after Ivor-Lewis esophagectomy is always combined with anastomotic leakage of the esophagogastrostomy. Treatment options primarily depend on the vascularization of the gastric conduit, the severity of the concomitant aspiration pneumonia, and the volume of the air leakage.
Authors: Stephen H Bailey; David A Bull; David H Harpole; Jeffrey J Rentz; Leigh A Neumayer; Theodore N Pappas; Jennifer Daley; William G Henderson; Barbara Krasnicka; Shukri F Khuri Journal: Ann Thorac Surg Date: 2003-01 Impact factor: 4.330
Authors: Asad Kutup; Michael F Nentwich; Elfriede Bollschweiler; Dean Bogoevski; Jakob R Izbicki; Arnulf H Hölscher Journal: Ann Surg Date: 2014-12 Impact factor: 12.969
Authors: Donald E Low; Derek Alderson; Ivan Cecconello; Andrew C Chang; Gail E Darling; Xavier Benoit DʼJourno; S Michael Griffin; Arnulf H Hölscher; Wayne L Hofstetter; Blair A Jobe; Yuko Kitagawa; John C Kucharczuk; Simon Ying Kit Law; Toni E Lerut; Nick Maynard; Manuel Pera; Jeffrey H Peters; C S Pramesh; John V Reynolds; B Mark Smithers; J Jan B van Lanschot Journal: Ann Surg Date: 2015-08 Impact factor: 12.969
Authors: Pieter C van der Sluis; Roy J J Verhage; Sylvia van der Horst; Willem M van der Wal; Jelle P Ruurda; Richard van Hillegersberg Journal: Dig Surg Date: 2014-06-05 Impact factor: 2.588
Authors: Abeel A Mangi; Henning A Gaissert; Cameron D Wright; James S Allan; John C Wain; Hermes C Grillo; Douglas J Mathisen Journal: Ann Thorac Surg Date: 2002-03 Impact factor: 4.330
Authors: T W Rice; V W Rusch; C Apperson-Hansen; M S Allen; L-Q Chen; J G Hunter; K A Kesler; S Law; T E M R Lerut; C E Reed; J A Salo; W J Scott; S G Swisher; T J Watson; E H Blackstone Journal: Dis Esophagus Date: 2009 Impact factor: 3.429
Authors: Felix Berlth; Marc Bludau; Patrick Sven Plum; Till Herbold; Hildegard Christ; Hakan Alakus; Robert Kleinert; Christiane Josephine Bruns; Arnulf Heinrich Hölscher; Seung-Hun Chon Journal: J Gastrointest Surg Date: 2018-10-29 Impact factor: 3.452
Authors: Julia K Grass; Natalie Küsters; Fabien L von Döhren; Nathaniel Melling; Tarik Ghadban; Thomas Rösch; Marcel Simon; Jakob R Izbicki; Alexandra König; Matthias Reeh Journal: Cancers (Basel) Date: 2022-02-26 Impact factor: 6.639